Responding When an Allocator Asks About Strategy Capacity
A careful way for institutional sales teams to handle capacity questions using approved evidence.
Capacity questions deserve precision because an allocator is often asking two different things: whether the strategy can accept a possible allocation today and how future asset growth could affect implementation. A salesperson should not turn either question into a promise without defined limits. The useful response explains what is documented and brings in the right approved source.
First clarify the allocation context. Ask about the approximate mandate size, expected funding schedule, and any liquidity or concentration requirement that makes capacity material. Then distinguish the allocator’s question from a prediction about flows. Their research team may need a published capacity framework, a current asset figure, or a conversation with an investment professional under the firm’s review process.
During a call, a corporate plan analyst asks, “Can this strategy take a large mandate next year?” The rep says, “I want to make sure I address the decision behind that question. Are you testing the strategy’s documented capacity approach, a funding schedule, or both?” The analyst says both. The rep continues, “I can provide approved material describing the capacity framework and ask the appropriate team what current information can be shared. I will not characterize future availability before that review.”
This answer is direct without overreaching. Practice it by giving a rep three versions of the question: one about an immediate search, one about a future transition, and one about a redemption rumor. Review whether the rep asks for context, avoids forecasting, and names the evidence owner before promising a follow-up.
The follow-up note should separate published capacity information from the allocator’s potential mandate, requested funding schedule, and internal questions. That distinction tells reviewers what is factual, what is client context, and what still awaits authorization before it is discussed.
Practice these next
Guide institutional sales teams through a careful conversation about a concentrated legacy holding.
Guide institutional sales teams through early fee questions without inventing commercial terms.
Guide an insurer duration discussion toward documented assumptions and the right diligence owners.
Give institutional sales teams a disciplined way to describe process, risk, and evidence.
Teach institutional sales teams to map stakeholders without assuming influence.
Help institutional sales teams support a search led by a consultant while respecting the allocator's process.